Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
Thermo Fisher Scientific Inc. (TMO) had Cash Flow from Financial Activities of $1.80B for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$12.21B |
|
$1.96B |
|
$7.14B |
|
$5.07B |
|
$9.96B |
|
$2.26B |
|
$-102.00M |
|
$2.15B |
|
$2.15B |
|
$2.00B |
|
$1.97B |
|
$1.97B |
|
$2.00B |
|
$2.26B |
|
-- |
|
376.00M |
|
377.00M |
|
$5.22 |
|
$5.21 |
|
| Balance Sheet Financials | |
$28.71B |
|
$10.56B |
|
$81.64B |
|
$110.34B |
|
$15.19B |
|
$35.85B |
|
$41.74B |
|
$56.93B |
|
-- |
|
$-11.79B |
|
$53.41B |
|
-- |
|
| Cash Flow Statement Financials | |
$7.82B |
|
$-4.05B |
|
|
Cash Flow from Financial Activities |
$1.80B |
$4.04B |
|
$9.88B |
|
$5.84B |
|
-- |
|
$-636.00M |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|